EPA power grab to control private property around ditches:
“Lawmakers are working to block an unprecedented power grab by the Environmental Protection Agency to use the Clean Water Act (CWA) and control land alongside ditches, gullies and other ephemeral spots by claiming the sources are part of navigable waterways….”
Link: http://www.humanevents.com/2012/06/11/epa-power-grab-to-regulate-ditches-gullies-on-private-property/
Retracted Publications in the Drug Literature.
Samp JC, Schumock GT, Pickard AS.
Source
Center for Pharmacoeconomic Research, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois.
Abstract
Recent studies have suggested an increase in the number of retracted scientific publications. It is unclear how broadly the issue of misleading and fraudulent publications pertains to retractions of drug therapy studies. Therefore, we sought to determine the trends and factors associated with retracted publications in drug therapy literature. A PubMed search was conducted to identify retracted drug therapy articles published from 2000-2011. Articles were grouped according to reason for retraction, which was classified as scientific misconduct or error. Scientific misconduct was further divided into data fabrication, data falsification, questions of data veracity, unethical author conduct, and plagiarism. Error was defined as duplicate publication, scientific mistake, journal error, or unstated reasons
EPA power grab to control private property around ditches:
“Lawmakers are working to block an unprecedented power grab by the Environmental Protection Agency to use the Clean Water Act (CWA) and control land alongside ditches, gullies and other ephemeral spots by claiming the sources are part of navigable waterways….”
Link: http://www.humanevents.com/2012/06/11/epa-power-grab-to-regulate-ditches-gullies-on-private-property/
Junk Science Week at Canada’s National Post newspaper is a must-read:
http://opinion.financialpost.com/2012/06/11/terence-corcoran-welcome-to-junk-science-week-2012/
Nice junk science collection:
Retracted Publications in the Drug Literature.
Samp JC, Schumock GT, Pickard AS.
Source
Center for Pharmacoeconomic Research, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois.
Abstract
Recent studies have suggested an increase in the number of retracted scientific publications. It is unclear how broadly the issue of misleading and fraudulent publications pertains to retractions of drug therapy studies. Therefore, we sought to determine the trends and factors associated with retracted publications in drug therapy literature. A PubMed search was conducted to identify retracted drug therapy articles published from 2000-2011. Articles were grouped according to reason for retraction, which was classified as scientific misconduct or error. Scientific misconduct was further divided into data fabrication, data falsification, questions of data veracity, unethical author conduct, and plagiarism. Error was defined as duplicate publication, scientific mistake, journal error, or unstated reasons
http://www.ncbi.nlm.nih.gov/pubmed/22581659